Research Background
With the aggravation of the aging population and the increase in work and life pressure, male diseases are increasing at a rate of 3% per year, seriously threatening the healthy life of men. Among them, premature ejaculation (PE), erectile dysfunction (ED), and chronic prostateitis (CP) are the "three great mountains" that are crushing contemporary men. At the same time, as income increases, the attention and investment of Chinese men in their own health are also increasing continuously. According to Frost&Sullivan's prediction, the size of China's male health and wellness market is expected to reach RMB 9.96 billion by 2025, showing huge market potential and growth space.
Project Overview 01 Introduction and Advantages of Innovative Drug Pipeline 1. XX Capsule: Targeting age-related disease "benign prostatic hyperplasia", it can replace the current combination therapy (5a-reductase inhibitors + alpha-receptor blockers) with a single drug, solving the pain point of "night urination" without a drug to treat, and without side effects of sexual function impairment. 2b clinical trial will be unveiled in September 2024, and 3rd phase clinical trial will be launched at the end of 2024. 02 Advantages of the Health and Wellness Product Line Project Value Advantages of the Project Fundraising Plan A round of financing, raising $15-$20 million.
2. XX Granule: Targeting genital herpes, it has dual effects of anti-viral and immune regulation, solving the pain point of high recurrence rate of genital herpes (currently there is no drug to treat), and significantly reducing the recurrence rate. It has completed the pilot production, and will apply for IND in 2025.
3. XX Capsule: Targeting ED and premature ejaculation, it has dual effects, and is safe for middle-aged and elderly men with ED and premature ejaculation. It is in the pre-clinical research stage, and will apply for IND in 2025.
4. XX Capsule: Targeting male infertility, it solves the pain point of low sperm motility without a definite drug, and significantly improves sperm motility. It is in the pre-clinical research stage, and will apply for IND in 2025.
2. BaoYang Herbal Solid Drink: Improves sperm vitality, boosts Yang Qi (energy) and slows down the decline of male sexual function.
Focused on male health, with high capital market valuation; the golden 10-year period for traditional Chinese medicine innovative drugs.
2. Good team:
The founder is a composite talent with a doctorate in male health and a postdoctoral degree in traditional Chinese medicine. He has served as the technical director, product director, board secretary, and director of a pharmaceutical listed company. With over 20 years of experience in the male health field, he has rich clinical, new drug development, market positioning, and investment and acquisition experience in the fields of male health medicine and pharmacy. The company's team includes the R&D director, production director, and sales director of a pharmaceutical listed company, with strong capabilities.
3. Good products:
Four innovative traditional Chinese medicine drugs for male health and health products with independent intellectual property rights, with obvious clinical advantages and broad market prospects.
Purpose: To conduct Phase IIb clinical research on Tianhu Jiaonang, pharmacological, pharmacodynamic, and safety evaluation studies on Qiangjing Jiaonang and Chutie Keli.
